These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30887112)

  • 1. Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α.
    Pontoriero M; Fiume G; Vecchio E; de Laurentiis A; Albano F; Iaccino E; Mimmi S; Pisano A; Agosti V; Giovannone E; Altobelli A; Caiazza C; Mallardo M; Scala G; Quinto I
    J Mol Med (Berl); 2019 May; 97(5):675-690. PubMed ID: 30887112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's tyrosine kinase is required for activation of IkappaB kinase and nuclear factor kappaB in response to B cell receptor engagement.
    Petro JB; Rahman SM; Ballard DW; Khan WN
    J Exp Med; 2000 May; 191(10):1745-54. PubMed ID: 10811867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
    Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
    J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B.
    Mizuno T; Rothstein TL
    J Immunol; 2003 Mar; 170(6):2806-10. PubMed ID: 12626529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton's tyrosine kinase inhibition induces rewiring of proximal and distal B-cell receptor signaling in mice.
    Rip J; de Bruijn MJW; Neys SFH; Singh SP; Willar J; van Hulst JAC; Hendriks RW; Corneth OBJ
    Eur J Immunol; 2021 Sep; 51(9):2251-2265. PubMed ID: 34323286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFkappaB activation by lipopolysaccharide.
    Doyle SL; Jefferies CA; O'Neill LA
    J Biol Chem; 2005 Jun; 280(25):23496-501. PubMed ID: 15849198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase C-gamma 2 couples Bruton's tyrosine kinase to the NF-kappaB signaling pathway in B lymphocytes.
    Petro JB; Khan WN
    J Biol Chem; 2001 Jan; 276(3):1715-9. PubMed ID: 11042193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms.
    Antony P; Petro JB; Carlesso G; Shinners NP; Lowe J; Khan WN
    Exp Cell Res; 2003 Nov; 291(1):11-24. PubMed ID: 14597404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
    Karin M; Ben-Neriah Y
    Annu Rev Immunol; 2000; 18():621-63. PubMed ID: 10837071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes.
    Tan JE; Wong SC; Gan SK; Xu S; Lam KP
    J Biol Chem; 2001 Jun; 276(23):20055-63. PubMed ID: 11274146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bruton's tyrosine kinase targets NF-kappaB to the bcl-x promoter via a mechanism involving phospholipase C-gamma2 following B cell antigen receptor engagement.
    Petro JB; Castro I; Lowe J; Khan WN
    FEBS Lett; 2002 Dec; 532(1-2):57-60. PubMed ID: 12459462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.
    Rozovski U; Harris DM; Li P; Liu Z; Jain P; Veletic I; Ferrajoli A; Burger J; Thompson P; Jain N; Wierda W; Keating MJ; Estrov Z
    Int J Cancer; 2017 Nov; 141(10):2076-2081. PubMed ID: 28722170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C beta controls nuclear factor kappaB activation in B cells through selective regulation of the IkappaB kinase alpha.
    Saijo K; Mecklenbräuker I; Santana A; Leitger M; Schmedt C; Tarakhovsky A
    J Exp Med; 2002 Jun; 195(12):1647-52. PubMed ID: 12070292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell receptor signaling down-regulates forkhead box transcription factor class O 1 mRNA expression via phosphatidylinositol 3-kinase and Bruton's tyrosine kinase.
    Hinman RM; Bushanam JN; Nichols WA; Satterthwaite AB
    J Immunol; 2007 Jan; 178(2):740-7. PubMed ID: 17202334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Src mediates thrombin-induced NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells.
    Lin CH; Cheng HW; Hsu MJ; Chen MC; Lin CC; Chen BC
    J Immunol; 2006 Sep; 177(5):3427-38. PubMed ID: 16920985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated constitutive IkappaB kinase activity and IkappaB-alpha phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-alpha transcription.
    Devalaraja MN; Wang DZ; Ballard DW; Richmond A
    Cancer Res; 1999 Mar; 59(6):1372-7. PubMed ID: 10096573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase.
    Khan WN
    Immunol Res; 2001; 23(2-3):147-56. PubMed ID: 11444380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoralidin inhibits LPS-induced iNOS expression via repressing Syk-mediated activation of PI3K-IKK-IκB signaling pathways.
    Chiou WF; Don MJ; Liao JF; Wei BL
    Eur J Pharmacol; 2011 Jan; 650(1):102-9. PubMed ID: 20951127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma.
    Mizuno T; Rothstein TL
    J Immunol; 2005 May; 174(10):6062-70. PubMed ID: 15879100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation.
    Kirchner D; Duyster J; Ottmann O; Schmid RM; Bergmann L; Munzert G
    Exp Hematol; 2003 Jun; 31(6):504-11. PubMed ID: 12829026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.